Patents Assigned to CHF Solutions, Inc.
-
Publication number: 20040176813Abstract: A method and system for the extracorporeal treatment of blood to remove fluid from the fluid overloaded patient is disclosed that non-invasively measures an oxygen level in the venous blood. The oxygen blood level is used to detect when hypotension is about to occur in a patient. The oxygen level measurements are used as feedback signals. These feedback signals are applied to automatically control the rate of fluid extraction to achieve the desired clinical outcome and avoid precipitating a hypotensive crisis in the patient.Type: ApplicationFiled: March 16, 2004Publication date: September 9, 2004Applicant: CHF Solutions Inc.Inventors: Mark Gelfand, John O'Mahony, Howard R. Levin
-
Patent number: 6773412Abstract: A graphical user interface for a medical instruments for a Renal Replacement Therapy is disclosed that includes a pictogram representation of the fluid path of an extracorporeal blood circuit that represents fluid lines, pumps and sensors. To assist the user in responding to alarms and rectifying faults in the system the source of a potential trouble is animated. The location of a trouble spot is easily identified by flashing of the corresponding element of the pictogram, change of color or thickness of a corresponding line.Type: GrantFiled: April 13, 2001Date of Patent: August 10, 2004Assignee: CHF Solutions, Inc.Inventors: John J. O'Mahony, Andrew Hal Pert, Mark Gelfand
-
Publication number: 20040084358Abstract: A graphical user interface for a medical instruments for a Renal Replacement Therapy is disclosed that includes a pictogram representation of the fluid path of an extracorporeal blood circuit that represents fluid lines, pumps and sensors. To assist the user in responding to alarms and rectifying faults in the system the source of a potential trouble is animated. The location of a trouble spot is easily identified by flashing of the corresponding element of the pictogram, change of color or thickness of a corresponding line.Type: ApplicationFiled: August 19, 2003Publication date: May 6, 2004Applicant: CHF Solutions, Inc.Inventors: John J. O'Mahony, Andrew Hal Pert, Mark Gelfand
-
Publication number: 20040054315Abstract: A method and apparatus for ultrafiltration of blood operating by removing blood from a peripheral blood vessel at a rate of less than two percent of total cardiac output of a patient, extracting fluid at a rate of 0.1 liter to 1.0 liters per hour while retaining cells and proteins in the blood, and returning the concentrated blood to a secondary blood vessel is disclosed. Blood is removed and returned using small gage needles. As a pump circulates blood from the patient, a filter removes ultrafiltrate from the blood using duty cycle or pump control, and a transparent container collects the removed fluid.Type: ApplicationFiled: August 19, 2003Publication date: March 18, 2004Applicant: CHF Solutions, Inc.Inventors: Howard R. Levin, Mark Gelfand, John O'Mahony, Hans-Dietrich Polaschegg
-
Patent number: 6706007Abstract: A method and system for the extracorporeal treatment of blood to remove fluid from the fluid overloaded patient is disclosed that non-invasively measures an oxygen level in the venous blood. The oxygen blood level is used to detect when hypotension is about to occur in a patient. The oxygen level measurements are used as feedback signals. These feedback signals are applied to automatically control the rate of fluid extraction to achieve the desired clinical outcome and avoid precipitating a hypotensive crisis in the patient.Type: GrantFiled: December 29, 2000Date of Patent: March 16, 2004Assignee: CHF Solutions, Inc.Inventors: Mark Gelfand, John O'Mahoney, Howard R. Levin
-
Publication number: 20040044302Abstract: An extracorpeal blood circuit for removal of contrast from human blood using a filter and withdrawal filter pump and a by-pass pump. The withdrawal filter blood pump operates when a contrast bolus has been detected. Otherwise the bypass blood pump maintains physiological blood flow from the coronary sinus preventing the need for deflation and re-inflation of the balloon catheter. When contrast is detected blood the bypass blood pump is stopped to prevent contrast from leaking back into the patients circulatory system via the bypass pump and CS blood flow is maintained at its physiological blood flow resulting in the heart being oblivious to the transition by the prefilter blood pump.Type: ApplicationFiled: September 3, 2003Publication date: March 4, 2004Applicant: CHF Solutions, Inc.Inventors: Steven J. Bernard, John J. O'Mahony, Andrew J. Halpert, Mark Gelfand, Howard R. Levin
-
Publication number: 20040044301Abstract: Method and apparatus for the extracorporeal treatment of blood by utilizing a peripherally inserted catheter assembly for the continuous removal of blood for renal replacement treatment, in particularly, treatment of congestive heart failure and fluid overload by ultrafiltration. A catheter is inserted in a peripheral vein and maneuvered upward through the vascular system to access the reservoir of blood in the large or great veins for continuous blood withdrawal and treatment. Air-tight connectors are incorporated in the catheter assembly to overcome the untoward effects of negative pressure in blood withdrawal.Type: ApplicationFiled: August 26, 2003Publication date: March 4, 2004Applicant: CHF Solutions, Inc.Inventors: Howard R. Levin, Mark Gelfand, Steve J. Bernard
-
Publication number: 20040039324Abstract: A method and system for the extracorporeal treatment of blood to remove fluid from the fluid overloaded patient is disclosed that non-invasively measures osmotic pressure across a filter membrane of a blood filter. The filter is permeable to water and electrolytes, but not to blood protein. The osmotic pressure indicates the protein concentration in the blood. Osmotic pressure is used to detect when hypotension is about to occur in a patient, as a result of excessive blood volume reduction during treatment of the blood. Using the osmotic pressure measurement as a feedback signal, the rate of fluid extraction is automatically controlled to achieve the desired clinical outcome and avoid precipitating a hypotensive crisis in the patient.Type: ApplicationFiled: August 27, 2003Publication date: February 26, 2004Applicant: CHF Solutions, Inc.Inventors: Mark Gelfand, John J. O'Mahony, Howard R. Levin
-
Patent number: 6695806Abstract: An integrated disposable set for dialysis or ultrafiltration treatment of blood is disclosed that includes a memory “key” chip. The key contains information relating to the set, including calibration for sensors, model and date of manufacture and a proprietary secret code to prevent unauthorized duplication of a circuit. The key is activated when treatment of a patient begins to prevent reuse of the set and a delay in use of the set that is too long. Patient data and operational information can be stored in the key during treatment. The key can be returned to the manufacturer or entered into hospital database for analysis. The key is preferably an EEPROM chip that can be embedded in an integral circuit sensor or a separate plug in device, such as a code card.Type: GrantFiled: October 17, 2002Date of Patent: February 24, 2004Assignee: CHF Solutions, Inc.Inventors: Mark Gelfand, John J. O'Mahony
-
Publication number: 20040030277Abstract: A method and apparatus for controlling blood withdrawal and infusion flow rate with the use of a pressure controller. The pressure controller uses pressure targets based upon occlusion limits that are calculated as a function of flow. The controller has the ability to switch from controlling withdrawal pressure to controlling infusion pressure based upon the detection of an occlusion. The controller distinguishes between partial and total occlusions of the withdrawal vein providing blood access. Depending on the nature of occlusion, the controller limits or temporarily reverses blood flow and, thus, prevents withdrawal vessel collapse or reverses blood flow to quickly infuse blood into the vessel without participation from operator.Type: ApplicationFiled: June 24, 2003Publication date: February 12, 2004Applicant: CHF Solutions, Inc.Inventors: John J. O'Mahony, Mark Gelfand, Edward G. Rychlick
-
Patent number: 6689083Abstract: A method and system for the extracorporeal treatment of blood to remove fluid from the fluid overloaded patient is disclosed that non-invasively measures osmotic pressure across a filter membrane of a blood filter. The filter is permeable to water and electrolytes, but not to blood protein. The osmotic pressure indicates the protein concentration in the blood. Osmotic pressure is used to detect when hypotension is about to occur in a patient, as a result of excessive blood volume reduction during treatment of the blood. Using the osmotic pressure measurement as a feedback signal, the rate of fluid extraction is automatically controlled to achieve the desired clinical outcome and avoid precipitating a hypotensive crisis in the patient.Type: GrantFiled: November 27, 2000Date of Patent: February 10, 2004Assignee: CHF Solutions, Inc.Inventors: Mark Gelfand, John J. O'Mahony, Howard R. Levin
-
Patent number: 6685664Abstract: Method and apparatus for the extracorporeal treatment of blood by utilizing a peripherally inserted catheter assembly for the continuous removal of blood for renal replacement treatment, in particularly, treatment of congestive heart failure and fluid overload by ultrafiltration. A catheter is inserted in a peripheral vein and maneuvered upward through the vascular system to access the reservoir of blood in the large or great veins for continuous blood withdrawal and treatment. Air-tight connectors are incorporated in the catheter assembly to overcome the untoward effects of negative pressure in blood withdrawal.Type: GrantFiled: June 8, 2001Date of Patent: February 3, 2004Assignee: CHF Solutions, Inc.Inventors: Howard R. Levin, Mark Gelfand, Steve Bernard
-
Patent number: 6592567Abstract: A kidney perfusion catheter assembly is disclosed having an introducer catheter, a renal artery seal, a perfusion tip, and a guide wire. The perfusion catheter provides a flow of supplemental blood to increase the local blood pressure in the renal artery and to perfuse the kidney. The introducer catheter is maneuvered through the femoral artery to the aorta and positioned at the branch of a renal artery. The perfusion catheter tip is telescoped from the distal end of the introducer catheter into the renal artery. A blood pump attached to the proximal end of the perfusion catheter assembly provides a flow of blood that streams from the perfusion catheter tip into the renal artery. This stream of blood increases the pressure and volume of the blood flowing through the renal artery. The catheter includes a seal to block the opening of the renal artery to prevent the runoff of the blood from the renal artery into the aorta.Type: GrantFiled: December 7, 1999Date of Patent: July 15, 2003Assignee: CHF Solutions, Inc.Inventors: Howard R. Levin, Mark Gelfand, Steve Bernard
-
Patent number: 6585675Abstract: A method and apparatus for controlling blood withdrawal and infusion flow rate with the use of a pressure controller. The pressure controller uses pressure targets based upon occlusion limits that are calculated as a function of flow. The controller has the ability to switch from controlling withdrawal pressure to controlling infusion pressure based upon the detection of an occlusion. The controller distinguishes between partial and total occlusions of the withdrawal vein providing blood access. Depending on the nature of occlusion, the controller limits or temporarily reverses blood flow and, thus, prevents withdrawal vessel collapse or reverses blood flow to quickly infuse blood into the vessel without participation from operator.Type: GrantFiled: November 2, 2000Date of Patent: July 1, 2003Assignee: CHF Solutions, Inc.Inventors: John J. O'Mahony, Mark Gelfand, Edward G. Rychlick
-
Patent number: 6533747Abstract: An extracorporeal blood circuit is disclosed for withdrawing, filtering and returning blood from peripheral blood vessels. The blood passage in the circuit extends through a withdrawal tube connected to a catheter in a peripheral vein, a filter, one or more pressure sensors and return tube also connected to a catheter in a peripheral vein (which may or may not be the same vein as used for the withdrawal tube). The blood passage is air free, and has smooth passage walls which promoted continuous and uniform flow of the blood through the circuit.Type: GrantFiled: October 30, 2000Date of Patent: March 18, 2003Assignee: CHF Solutions, Inc.Inventors: Hans-Dietrich Polaschegg, Steven Bernard, Howard R. Levin, Mark Gelfand
-
Patent number: 6514226Abstract: A method for treating congestive heart failure (CHF) has been developed that restores kidney renal functions by artificially perfusion of at least one kidney. The kidney is perfused with the patient's blood or other suitable perfusion fluid. A catheter inserted into the aorta of the patient has a distal end that supplies the perfusion fluid into a renal artery of the patient. The catheter may be coupled to an implanted blood pump or to an external supply of perfusion pressure. The restoration of kidney function assists the heart by removing excess fluid, urine and toxin from the patient, and by normalizing the patient's renin-angiotensin system and other neurohormonal substances. The method is applicable to treat chronic and acute CHF.Type: GrantFiled: February 10, 2000Date of Patent: February 4, 2003Assignee: CHF Solutions, Inc.Inventors: Howard R. Levin, Mark Gelfand
-
Patent number: 6468241Abstract: An integrated disposable set for dialysis or ultrafiltration treatment of blood is disclosed that includes a memory “key” chip. The key contains information relating to the set, including calibration for sensors, model and date of manufacture and a proprietary secret code to prevent unauthorized duplication of a circuit. The key is activated when treatment of a patient begins to prevent reuse of the set and a delay in use of the set that is too long. Patient data and operational information can be stored in the key during treatment. The key can be returned to the manufacturer or entered into hospital database for analysis. The key is preferably an EEPROM chip that can be embedded in an integral circuit sensor or a separate plug in device, such as a code card.Type: GrantFiled: October 26, 2000Date of Patent: October 22, 2002Assignee: CHF Solutions, Inc.Inventors: Mark Gelfand, John J. O'Mahony
-
Patent number: D476730Type: GrantFiled: April 3, 2002Date of Patent: July 1, 2003Assignee: CHF Solutions, Inc.Inventors: John J. O'Mahony, Steven Bernard, Douglas Francis Walker
-
Patent number: D477867Type: GrantFiled: April 3, 2002Date of Patent: July 29, 2003Assignee: CHF Solutions, Inc.Inventors: John J. O'Mahony, Steven Bernard, Douglas Francis Walker
-
Patent number: D479320Type: GrantFiled: April 3, 2002Date of Patent: September 2, 2003Assignee: CHF Solutions, Inc.Inventors: John J. O'Mahony, Steven Bernard, Douglas Francis Walker